September 1st, 2011 by Ryan Luce No Comments
Written by Michael O'Leary
With all the new FDA-approved drugs for type 2 diabetes lately, the question arises, is your current prescription the best for you? With names like Onglyza, Januvia, Byetta, Prandin, Tradjenta, metformin, Amaryl, it can be confusing even to know what to ask your doctor.
In a “best evidence review” published Aug. 30 in MedScape News, Dr. Charles Vega, associate professor in the Department of Family Medicine at the University of California, Irvine, compares the effectiveness and safety of all the medications for type 2 including the newest ones being marketed. At least that’s what he wanted to do. (Link to published site)
